{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T13:14:55Z","timestamp":1722863695917},"reference-count":21,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2014,9,17]],"date-time":"2014-09-17T00:00:00Z","timestamp":1410912000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0107316","type":"journal-article","created":{"date-parts":[[2014,9,17]],"date-time":"2014-09-17T18:42:38Z","timestamp":1410979358000},"page":"e107316","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["Progress toward a Universal H5N1 Vaccine: A Recombinant Modified Vaccinia Virus Ankara-Expressing Trivalent Hemagglutinin Vaccine"],"prefix":"10.1371","volume":"9","author":[{"given":"Mookkan","family":"Prabakaran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonja","family":"Leyrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Auer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subaschandrabose R.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathrin","family":"Kindsmueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nutan","family":"Mytle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joerg","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Lockhart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jimmy","family":"Kwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,9,17]]},"reference":[{"key":"ref1","unstructured":"World Health Organization (WHO) Cumulative number of confirmed human cases for avian influenza A (H5N1) reported to WHO, 2003\u20132013. Available: http:\/\/www.who.int\/influenza\/human_animal_interface\/EN_GIP_20140124CumulativeNumberH5N1cases.pdf?ua=1<\/ext-link> Accessed April 27, 2014."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"11822","DOI":"10.1128\/JVI.00891-10","article-title":"Neutralizing epitopes of influenza virus hemagglutinin: target for the development of a universal vaccine against H5N1 lineages","volume":"84","author":"M Prabakaran","year":"2010","journal-title":"J Virol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.4049\/jimmunol.0803467","article-title":"Vaccinia virus-based multivalent H5N1 avian influenza vaccines adjuvanted with IL-15 confer sterile cross-clade protection in mice","volume":"82","author":"LL Poon","year":"2009","journal-title":"J Immunol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1128\/JVI.00969-09","article-title":"Efficacy of multivalent adenovirus-based vaccine against simian immunodeficiency virus challenge","volume":"84","author":"DR Casimiro","year":"2010","journal-title":"J Virol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.coi.2011.03.006","article-title":"Viral vectors as vaccine platforms: deployment in sight","volume":"23","author":"CS Rollier","year":"2011","journal-title":"Curr Opin Immunol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1086\/421266","article-title":"Modified vaccinia Ankara: potential as an alternative smallpox vaccine","volume":"38","author":"LH McCurdy","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.3201\/eid1110.050644","article-title":"Evolution of H5N1 avian influenza viruses in Asia","volume":"11","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"e4566","DOI":"10.1371\/journal.pone.0004566","article-title":"Development of epitope-blocking ELISA for universal detection of antibodies to human H5N1 influenza viruses","volume":"4","author":"M Prabakaran","year":"2009","journal-title":"PLoS One"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0264-410X(91)90055-B","article-title":"Efficacy of nucleoprotein and hemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens","volume":"9","author":"RG Webster","year":"1991","journal-title":"Vaccine"},{"key":"ref10","unstructured":"Centers for Disease Control and Prevention (U.S.), and National Institutes of Health (U.S.) (1999) Biosafety in microbiological and biomedical laboratories, 4th ed. Washington [Bethesda, Md.].Washington, D.C.: U.S. Dept. of Health and Human Services Public Health Service Centers for Disease Control and Prevention; National Institutes of Health; For sale by the Supt. of Docs. U.S. G.P.O."},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.vaccine.2013.01.003","article-title":"Cross-protective efficacy of bivalent recombinant baculoviral vaccine against heterologous influenza H5N1 challenge","volume":"31","author":"M Prabakaran","year":"2013","journal-title":"Vaccine"},{"key":"ref12","first-page":"360675","article-title":"Monoclonal Antibody Targeting Neutralizing Epitope on H5N1 Influenza Virus of clade 1 and 0 for Specific H5 Quantification","volume":"2013","author":"F He","year":"2013","journal-title":"Influenza Res Treat"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2307\/1591214","article-title":"Evaluation of different methods of inactivation of Newcastle disease virus and avian influenza virus in egg fluids and serum","volume":"35","author":"DJ King","year":"1991","journal-title":"Avian Dis"},{"key":"ref14","first-page":"493","article-title":"A simple method of estimating fifty percent endpoints","volume":"27","author":"LJ Reed","year":"1938","journal-title":"Am J Hyg"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1128\/JCM.37.4.937-943.1999","article-title":"Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays","volume":"37","author":"T Rowe","year":"1999","journal-title":"J Clin Microbiol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"12911","DOI":"10.1128\/JVI.01522-07","article-title":"Epitope mapping of the hemagglutinin molecule of a highly pathogenic H5N1 influenza virus by using monoclonal antibodies","volume":"81","author":"NV Kaverin","year":"2007","journal-title":"J Virol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"13538","DOI":"10.1073\/pnas.0806901105","article-title":"A consensus-hemagglutinin based DNA vaccine that protects mice against divergent H5N1 influenza viruses","volume":"105","author":"MW Chen","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1073\/pnas.1012457108","article-title":"Feasibility of reconstructed ancestral H5N1 influenza viruses for cross-clade protective vaccine development","volume":"108","author":"MF Ducatez","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/infdis\/jit414","article-title":"DNA prime and Virus-like particle boost from a single H5N1 strain elicits broadly neutralizing antibody responses against head region of H5 Hemagglutinin","volume":"209","author":"G Wang","year":"2014","journal-title":"J Infect Dis"},{"key":"ref20","unstructured":"World Health Organization (WHO) Summary of status of development and availability of A (H5N1) candidate vaccine viruses and potency testing reagents. Available: http:\/\/www.who.int\/influenza\/vaccines\/virus\/candidates_reagents\/summary_a_h5n1_cvv_20130813.pdf<\/ext-link>. Accessed March 18, 2014."},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1128\/JVI.06665-11","article-title":"A human antibody recognizing a conserved epitope of H5 hemagglutinin broadly neutralizes highly pathogenic avian influenza H5N1 viruses","volume":"86","author":"H Hu","year":"2012","journal-title":"J Virol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0107316","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T15:34:52Z","timestamp":1598283292000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0107316"}},"subtitle":[],"editor":[{"given":"Lanying","family":"Du","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,9,17]]},"references-count":21,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2014,9,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0107316","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,17]]}}}